Related Experiment Video
Updated: Mar 24, 2026

13:12
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
46.7K
Interpreting WAIS-III performance after primary brain tumor surgery.
Marta de A Gonçalves1, Mário R Simões2, Alexandre Castro-Caldas3
1a Laboratório de Estudos de Linguagem , Faculdade Medicina da Universidade Lisboa Avenida Professor Egas Moniz , Lisbon , Portugal.
Applied Neuropsychology. Adult
|March 5, 2016
Summary
This study found no specific Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) performance profile in brain tumor patients compared to controls. Despite some lower scores, all remained within normal ranges, indicating no distinct cognitive weaknesses.
Area of Science:
- Neuropsychology
- Cognitive Psychology
Background:
- Limited research exists on the cognitive performance of brain tumor patients using standardized intelligence scales.
- The Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) is a key tool for assessing cognitive function.
Purpose of the Study:
- To investigate the WAIS-III performance profile of patients with brain tumors.
- To compare the cognitive performance of brain tumor patients with demographically matched healthy controls.
Main Methods:
- Twenty-three brain tumor patients and 23 matched controls were assessed using the WAIS-III.
- Standardized score interpretation methods from the WAIS-III technical manual were applied.
- Demographic matching included gender, age, education, profession, and geographic region.
Main Results:
- Brain tumor patients exhibited significantly lower scores on Performance IQ, Full-Scale IQ, and several index/subtest scores (Perceptual Organization, Working Memory, Processing Speed, Arithmetic, Object Assembly, Picture Arrangement).
- All scaled scores for the brain tumor group remained within the normal range.
- Only Vocabulary and Comprehension scatter scores differed significantly between groups; no specific cognitive strengths or weaknesses were identified for either group.
Conclusions:
- The study did not identify a distinct WAIS-III performance profile for patients with brain tumors.
- Mean discrepancy scores lacked clinical significance in this patient population.
- Further research may be needed to understand subtle cognitive changes in brain tumor patients.
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
